Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions
A Standard patent application filed on 04 February 2003 credited to Biggadike, Keith

Details

Application number :
2003207016  
Application type :
Standard  
Application status :
LAPSED  
Under opposition :
No  
Proceeding type :
 
Invention title :
Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions  
Inventor :
Biggadike, Keith  
Agent name :
 
Address for service :
 
Filing date :
04 February 2003  
Associated companies :
 
Applicant name :
GLAXO GROUP LIMITED  
Applicant address :
Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN  
Old name :
 
Original Source :
Go  

Same Inventor